Average Co-Inventor Count = 10.71
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (23 from 116 patents)
2. Abbvie S.a.r.l. (8 from 15 patents)
3. Abbvie Overseas Sarl (5 from 5 patents)
4. Onco3r Therapeutics Bv (1 from 1 patent)
24 patents:
1. 12391679 - Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide, and -pyridazine compounds for treatment of inflammatory diseases
2. 12264156 - Compounds and pharmaceutical compositions thereof for the treatment of diseases
3. 12065443 - Compounds and pharmaceutical compositions thereof for the treatment of diseases
4. 11339166 - Compounds and pharmaceutical compositions thereof for the treatment of diseases
5. 11072611 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
6. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
7. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
8. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
9. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
10. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
11. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
12. 10526329 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
13. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
14. 10399940 - Substituted pyrrolidines and methods of use
15. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use